Lates News

Caribou Biosciences (CRBU.US): In the first quarter of 2025, revenue reached 2.353 million US dollars, down from 2.429 million US dollars, and higher than the expected value of 1.44 million US dollars; earnings per share were -0.43 US dollars, compared to -0.46 US dollars in the previous period, and better than the expected value of -0.48 US dollars.